Camp Lejeune cancer lawsuit

The CDC Study Also Links Certain Types Of Cancer Among Civilian Employees At Camp Lejeune To The Contaminated Water Supply

Investigators are certain that the area's water supply was contaminated and the Marine Corp failed to warn the base's civilian employees

Wednesday, August 10, 2022 - The CDC also conducted a study of mortality study among civilian employees living or working on the Camp Lejeune Marine Base in an attempt to link drinking Camp Lejeune water containing forever chemicals with an increased risk of dying from specific types of cancer. The contaminants included in the study were, trichloroethylene (TCE), tetrachloroethylene (also known as perchloroethylene or PCE), benzene, and two contaminants formed when TCE or PCE degrade in groundwater: 1,2-dichloroethylene and vinyl chloride, according to the CDC. It has been proven that the well water supplying the Camp Lejeune Marine Base was contaminated with the deadly, toxic chemicals for decades while the Marine Corp command did little to warn marines that they and their family members' lives were at risk. The marines are accused of underestimating the severity of the Camp Lejeune water contamination problem by failing to put forth an effort to alert families to the dangers. During the testing period under examination, hundreds of thousands of marines, civilian employees, and their families passed through the base and only the marines on the base when the health flyer went out, about one-tenth of one percent of all of the people, were alerted. Many marines and their family members have died and the survivors remain in the dark even today about the Marine Corp's improper and negligent waste disposal that caused toxic chemicals to drain into the area's groundwater for decades. Civilian employees of Camp Lejeune Marine Base should consider speaking with a Camp Lejeune cancer attorney and file a lawsuit once the Camp Lejeune Justice Act officially becomes law.

Another area covered by the recent CDC (Centers for Disease Control) Camp Lejeune drinking water contamination study looked at adverse birth outcomes. Included in the definition of adverse birth outcomes are pre-term births, those occurring before the 37th week, and fetal growth retardation, babies making it to at least the 37th week and weighing less than 2500 grams, according to the CDC website. The study analyzes births given by mothers who lived on the Camp Lejeune Marine base from 1968, the date when computerized birth records became available, and 1985 when the last of the contaminated wells were shut down. About 12,000 mothers' health records were examined. According to the CDC, "The study results suggest associations between in utero exposure to PCE, TCE and benzene in Camp Lejeune drinking water and adverse birth outcomes." The study found the greater the exposure to drinking water in utero, the higher the number of preterm births and birth defects. The CDC study falls short by failing to include stillbirths and deaths from childhood leukemia among service member families. If you have a spouse or child who has developed leukemia and lived at the Camp Lejeune Marine Base for at least 30-days between 1953 and 1987, you may qualify to file a Camp Lejeune water contamination lawsuit.

Information provided by CampLejeuneJusticeActClaim.com, a website devoted to providing news about Camp Lejeune Justice Act Claim, including a free no-cost, no-obligation Camp Lejeune Justice Act Claim.

More Recent Camp Lejeune Water Lawsuit News:

View all Camp Lejeune Justice Act Claim News

No-Cost, No-Obligation Claim Review for Persons or Families of Persons Who Developed Cancer After Spending 30 Days or More at Camp Lejeune between 1953 and 1988

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.